Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
M.D. Anderson Cancer Center
University of California, Irvine
Peking Union Medical College Hospital
University of Southern California
City of Hope Medical Center
MPN Research Foundation
Brigham and Women's Hospital
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Miami
M.D. Anderson Cancer Center
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Icahn School of Medicine at Mount Sinai
Hospices Civils de Lyon
Thomas Jefferson University
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
RWTH Aachen University
M.D. Anderson Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
University Hospital, Brest
IRCCS Azienda Ospedaliero-Universitaria di Bologna
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
M.D. Anderson Cancer Center
University of Birmingham
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
University Health Network, Toronto
University Hospital, Brest
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Institute of Hematology & Blood Diseases Hospital, China
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fox Chase Cancer Center
Federico II University
Queen's University, Belfast
University of Utah
Sohag University
University of Nebraska
University Health Network, Toronto
M.D. Anderson Cancer Center